Biochemical investigations performed in cases of mechanical asphyxia have provided diverging information over time. The purpose of the study presented herein was threefold: to investigate the postmortem stability of a series of molecules (thyroglobulin, iodothyronines, calcitonin, and parathyroid hormone) in blood after death, to determine the...
-
2018 (v1)PublicationUploaded on: February 14, 2024
-
2005 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2005 (v1)Publication
Objectives: The long-term virological efficacy of lopinavir/ritonavir-containing highly active antiretroviral therapy (HAART) in HIV-infected patients failing a first-line protease inhibitor (PI)-based regimen is still unclear. Methods: An observational study was carried out from December 2000-December 2002 on 111 consecutive patients starting...
Uploaded on: April 14, 2023 -
2005 (v1)Publication
The objective of this study was to find predictive factors of lopinavir/ritonavir (LPV/r) discontinuation for drug-related toxicities in highly pre-treated human immunodeficiency virus (HIV)-infected subjects. The study was an observational study of HIV patients starting LPV/r with HIV RNA >3 log10 copies/mL and a follow-up ≥6 months....
Uploaded on: May 13, 2023 -
2006 (v1)Publication
We studied 382 multiexperienced HIV-infected patients followed up for ≥3 months after starting lopinavir/ritonavir (LPV/r) to identify the factors predicting hypertriglyceridemia and high non-HDL cholesterol levels (triglycerides ≥200 mg/dl and/or non-HDL cholesterol ≥190 mg/dl) after 6 and 12 months of LPV/r exposure. The predictors of...
Uploaded on: April 14, 2023 -
2007 (v1)Publication
We evaluated the efficacy of tenofovir (TDF) - and didanosine (ddI)-containing backbones in HIV-infected experienced subjects. We included in the study 245 subjects who started a TDF/ddI-containing HAART with HIV-RNA > 3 log10 cp/ml and an available genotypic resistance test at baseline. At baseline, median CD4 counts and HIV-RNA were 278...
Uploaded on: April 14, 2023